FDA Panel Endorses Moderna Vaccine

A second coronavirus vaccine could get FDA authorization in a matter of days.

On Thursday, an FDA panel endorsed Moderna's vaccine, clearing the way for emergency authorization, potentially as soon as Friday.

Moderna's vaccine was more than 90% effective in late-stage clinical trials and does not require ultra-cold storage like the Pfizer vaccine. If approved, up to 6 million doses could be distributed within the U.S. next week.


Sponsored Content

Sponsored Content